For Erin Xie, this momentum previews how quickly the disaster could end, and which healthcare companies may continue to innovate for years to come.
Xie has found success investing in companies that produce this type of innovation. On an absolute-return basis that's not compared to any benchmark, her fund emerged on top out of all US-domiciled, open-ended peers that had run for 20 years as of April 30, according to Morningstar data. It returned 14.2% on average over the same timeframe.
It helps in healthcare investing when one has a scientific background. Xie earned a doctorate in biochemistry, and then got interested in the business side when she subsequently bagged an MBA from the Sloan School of Management.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »